These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22977986)

  • 21. Renal masses: urologic management.
    Ornstein DK; Arcangeli CG; Andriole GL
    Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):1-12. PubMed ID: 8995121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expanding role of imaging in the management of renal cell carcinoma.
    Murphy G; Jhaveri K
    Expert Rev Anticancer Ther; 2011 Dec; 11(12):1871-88. PubMed ID: 22117155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guideline 'Renal cell carcinoma'].
    Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma as second malignancy in patient with previous Wilms tumor.
    Lazarus J; Moolman C
    Urology; 2009 Sep; 74(3):598-600. PubMed ID: 19523667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
    Shah JB; Margulis V
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive surgery for renal cell carcinoma.
    Ghoneim IA; Fergany AF
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):989-97. PubMed ID: 19589037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermal ablation of renal cell carcinoma: triage, treatment, and follow-up.
    Thumar AB; Trabulsi EJ; Lallas CD; Brown DB
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S233-41. PubMed ID: 20656233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of the small renal mass: what is the most reasonable option?
    Ghavamian R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):977-80. PubMed ID: 21806319
    [No Abstract]   [Full Text] [Related]  

  • 29. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephron sparing surgery in patients with metastatic renal cell carcinoma.
    Krishnamurthi V; Novick AC; Bukowski R
    J Urol; 1996 Jul; 156(1):36-9. PubMed ID: 8648832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimally invasive nephron-sparing surgery.
    Berger A; Crouzet S; Canes D; Haber GP; Gill IS
    Curr Opin Urol; 2008 Sep; 18(5):462-6. PubMed ID: 18670268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EAU guidelines on renal cell carcinoma: the 2010 update.
    Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
    Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing the complex journey of renal cell carcinoma.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):53-4. PubMed ID: 17824565
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of localised renal cell carcinoma.
    Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
    Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current surgical approaches, nephron-sparing surgery, and the role of surgery in the integrated immunologic approach to renal-cell carcinoma.
    Novick AC
    Semin Oncol; 1995 Feb; 22(1):29-33. PubMed ID: 7855616
    [No Abstract]   [Full Text] [Related]  

  • 38. Case for nephron-sparing surgery in managing renal cell carcinoma.
    Taylor RJ
    Semin Urol; 1993 May; 11(2):104-11. PubMed ID: 8362119
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renal cell carcinoma. Significance of prognostic factors & current treatment].
    Fiori E; Gazzanelli S; Padovani A; De Cesare A; Costanzo F; Cangemi V; Piat G
    G Chir; 1995; 16(11-12):517-23. PubMed ID: 8679406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial colectomy required for resection of renal cell carcinoma: a case report and review of treatment options for locally advanced disease.
    Crotty KL; Macaluso JN
    J La State Med Soc; 2000 Mar; 152(3):119-23. PubMed ID: 10851826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.